Atom Investors LP Heron Therapeutics, Inc. Transaction History

Atom Investors LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$14.49 - $20.72 $370,233 - $529,416	-25,551 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$14.61 - $22.14 $159,994 - $242,455	10,951 Added 75.01%	25,551 $541,000
Q3 2020 Nov 13, 2020	BUY	$13.67 - $17.77 $199,582 - $259,442	14,600 New	14,600 $216,000
Q4 2019 Feb 13, 2020	SELL	$17.42 - $26.61 $528,156 - $806,788	-30,319 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$16.36 - $21.39 $496,018 - $648,523	30,319 New	30,319 $561,000
Q1 2019 May 15, 2019	SELL	$23.15 - $28.34 $1.39 Million - $1.7 Million	-60,074 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$22.03 - $32.01 $1.32 Million - $1.92 Million	60,074 New	60,074 $1.56 Million

185

130M

1.56M

27.1K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $157M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.